P-glycoprotein (P-gp) is one of several ABC transporters that can pump drugs out of tumor cells and thereby render chemotherapy ineffective. Overexpression of P-gp can give rise to multidrug resistance, making cancers quite difficult to treat. Several inhibitors of P-gp have been described, but none has entered the clinic, mainly because of poor efficacy or adverse reactions.